BN/CC isosterism in borazaronaphthalenes towards phosphodiesterase 10A (PDE10A) inhibitors

被引:58
|
作者
Vlasceanu, Alexandru [3 ]
Jessing, Mikkel [1 ,2 ]
Kilburn, John Paul [1 ,2 ]
机构
[1] H Lundbeck & Co AS, Discovery Chem, DK-2500 Valby, Denmark
[2] H Lundbeck & Co AS, DMPK, DK-2500 Valby, Denmark
[3] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark
关键词
Borazaronaphthalenes; PDE10A inhibitors; Antipsychotics; HETEROAROMATIC-COMPOUNDS; ENZYME-INHIBITORS; BORON COMPOUNDS; B-N; SCHIZOPHRENIA; 2,1-BORAZARONAPHTHALENES; SUBSTITUTION; DERIVATIVES; CHEMISTRY; DISCOVERY;
D O I
10.1016/j.bmc.2015.06.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The application of BN/CC isosterism is explored as a method of expanding the scope of core scaffolds in biologically active compounds. The viability of potential drug candidates incorporating BN-heteroaromatic moieties was investigated through the synthesis of BN-substituted analogs to known phosphodiesterase (PDE10A) inhibitors, namely MP10 and a selection of N-methylanilide analogs. These in some cases revealed unexpectedly potent and relatively stable derivatives, providing further support for the potential of BN-incorporation in medicinal chemistry. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4453 / 4461
页数:9
相关论文
共 50 条
  • [21] Phosphodiesterase 10A (PDE10A): Regulator of Dopamine Agonist-Induced Gene Expression in the Striatum
    Bonate, Ryan
    Kurek, Gabriela
    Hrabak, Michael
    Patterson, Santanna
    Padovan-Neto, Fernando
    West, Anthony R.
    Steiner, Heinz
    CELLS, 2022, 11 (14)
  • [22] Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies
    Hu, Essa
    Chen, Ning
    Kunz, Roxanne K.
    Hwang, Dah-Ren
    Michelsen, Klaus
    Davis, Carl
    Ma, Ji
    Shi, Jianxia
    Lester-Zeiner, Dianna
    Hungate, Randall
    Treanor, James
    Chen, Hang
    Allen, Jennifer R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07): : 719 - 723
  • [23] Development of a cell-based assay for screening of phosphodiesterase 10A (PDE10A) inhibitors using a stable recombinant HEK-293 cell line expressing high levels of PDE10A
    Bora, Roop Singh
    Gupta, Dikshi
    Malik, Renu
    Chachra, Sonia
    Sharma, Pratibha
    Saini, Kulvinder Singh
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2008, 49 (02) : 129 - 134
  • [24] Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer
    Borneman, Rebecca M.
    Gavin, Elaine
    Musiyenko, Alla
    Richter, Wito
    Lee, Kevin J.
    Crossman, David K.
    Andrews, Joel F.
    Wilhite, Annelise M.
    McClellan, Steven
    Aragon, Ileana
    Ward, Antonio B.
    Chen, Xi
    Keeton, Adam B.
    Berry, Kristy
    Piazza, Gary A.
    Scalici, Jennifer M.
    da Silva, Luciana Madeira
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [25] Identification of a Novel Orally Bioavailable Phosphodiesterase 10A (PDE10A) Inhibitor with Efficacy in Animal Models of Schizophrenia
    Manuel Bartolome-Nebreda, Jose
    Alonso de Diego, Sergio A.
    Artola, Marta
    Delgado, Francisca
    Delgado, Oscar
    Luz Martin-Martin, Maria
    Martinez-Viturro, Carlos M.
    Angel Pena, Miguel
    Min Tong, Han
    Van Gool, Michiel
    Manuel Alonso, Jose
    Fontana, Alberto
    Macdonald, Gregor J.
    Megens, Anton
    Langlois, Xavier
    Somers, Marijke
    Vanhoof, Greet
    Conde-Ceide, Susana
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (02) : 978 - 993
  • [26] Development of a positron emission tomography (PET) tracer to evaluate phosphodiesterase 10A (PDE10A) target engagement
    Chappell, Mark
    Tripp, Allie
    Bender, David
    Benesh, Dana
    Monk, Scott
    Chernet, Eyassu
    Rash, Karen
    Phebus, Lee
    Slieker, Lawrence
    Kuwabara, Hiroto
    Dannals, Robert
    Valentine, Heather
    Ravert, Hayden
    Wong, Dean
    Barth, Vanessa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [27] Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer
    Rebecca M. Borneman
    Elaine Gavin
    Alla Musiyenko
    Wito Richter
    Kevin J. Lee
    David K. Crossman
    Joel F. Andrews
    Annelise M. Wilhite
    Steven McClellan
    Ileana Aragon
    Antonio B. Ward
    Xi Chen
    Adam B. Keeton
    Kristy Berry
    Gary A. Piazza
    Jennifer M. Scalici
    Luciana Madeira da Silva
    Journal of Ovarian Research, 15
  • [28] AMG 580: A Novel Small Molecule Phosphodiesterase 10A (PDE10A) Positron Emission Tomography Tracer
    Chen, Hang
    Lester-Zeiner, Dianna
    Shi, Jianxia
    Miller, Silke
    Glaus, Charlie
    Hu, Essa
    Chen, Ning
    Able, Jessica
    Biorn, Christopher
    Wong, Jamie
    Ma, Ji
    Michelsen, Klaus
    Della Puppa, Geraldine Hill
    Kazules, Tim
    Dou, Hui Hannah
    Talreja, Santosh
    Zhao, Xiaoning
    Chen, Ada
    Rumfelt, Shannon
    Kunz, Roxanne K.
    Ye, Hu
    Thiel, Oliver R.
    Williamson, Toni
    Davis, Carl
    Porter, Amy
    Immke, David
    Allen, Jennifer R.
    Treanor, James
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (02): : 327 - 337
  • [29] Discovery of [11C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
    Cox, Christopher D.
    Hostetler, Eric D.
    Flores, Broc A.
    Evelhoch, Jeffrey L.
    Fan, Hong
    Gantert, Liza
    Holahan, Marie
    Eng, Waisi
    Joshi, Aniket
    McGaughey, Georgia
    Meng, Xiangjun
    Purcell, Mona
    Raheem, Izzat T.
    Riffel, Kerry
    Yan, Youwei
    Renger, John J.
    Smith, Sean M.
    Coleman, Paul J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4893 - 4898
  • [30] Fragment-assisted hit investigation involving integrated HTS and fragment screening: Application to the identification of phosphodiesterase 10A (PDE10A) inhibitors
    Varnes, Jeffrey G.
    Geschwindner, Stefan
    Holmquist, Christopher R.
    Forst, Janet
    Wang, Xia
    Dekker, Niek
    Scott, Clay W.
    Tian, Gaochao
    Wood, Michael W.
    Albert, Jeffrey S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (01) : 197 - 202